Christopher A. Kroeger

Chief Executive Officer at MapLight Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
1 year
Director since
2025

1 year of board service in total across 1 board, counting each seat separately. Longest: MapLight Therapeutics Inc., 1 year.

MapLight Therapeutics Inc. Director · Chief Executive Officer
1 year · Since 2025

Chief executive roles

MapLight Therapeutics Inc. · Chief Executive Officer
Since October 2025

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 15, 2026 MapLight Therapeutics Inc. Open-market sale −73,691 $8.08 $595,423
Aug 17, 2026 MapLight Therapeutics Inc. Grant or award +23,145 — —
Jul 17, 2026 MapLight Therapeutics Inc. Open-market sale −16,779 $37.90 $635,924
Jul 16, 2026 MapLight Therapeutics Inc. Open-market sale −40,899 $36.46 $1,491,178
Jul 16, 2026 MapLight Therapeutics Inc. Open-market sale −28,091 $37.26 $1,046,671
Jul 16, 2026 MapLight Therapeutics Inc. Open-market sale −92 $37.96 $3,492
Jul 15, 2026 MapLight Therapeutics Inc. Open-market sale −18,950 $36.00 $682,200
Jul 15, 2026 MapLight Therapeutics Inc. Open-market sale −42,738 $36.99 $1,580,879
Jul 15, 2026 MapLight Therapeutics Inc. Open-market sale −90 $37.54 $3,379
May 18, 2026 MapLight Therapeutics Inc. Open-market sale −118,037 $27.19 $3,209,426
May 18, 2026 MapLight Therapeutics Inc. Open-market sale −198 $28.15 $5,574
May 11, 2026 MapLight Therapeutics Inc. Open-market sale −342 $27.57 $9,429
May 11, 2026 MapLight Therapeutics Inc. Open-market sale −877 $28.70 $25,170
May 11, 2026 MapLight Therapeutics Inc. Open-market sale −6,871 $30.04 $206,405
May 11, 2026 MapLight Therapeutics Inc. Open-market sale −5,890 $30.56 $179,998

Questions about Christopher A. Kroeger

What boards is Christopher A. Kroeger on?

Christopher A. Kroeger sits on the board of MapLight Therapeutics Inc.

What company is Christopher A. Kroeger the CEO of?

Christopher A. Kroeger has been Chief Executive Officer of MapLight Therapeutics Inc. since October 2025.

How long has Christopher A. Kroeger served on boards?

Our records show at least 1 year of board service across 1 board, the earliest from 2025.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.